Back to top

Image: Bigstock

UnitedHealth (UNH) Plan in Indiana to Offer Pathways Program

Read MoreHide Full Article

UnitedHealth Group Incorporated (UNH - Free Report) recently announced that its UnitedHealthcare Community Plan of Indiana was among the four organizations chosen by the Family and Social Services Administration or FSSA of Indiana, to administer the Pathways for Aging program.

The plan from UNH was recommended by the health care and social services funding agency. The new program is expected to serve Medicaid beneficiaries aged 60 and above in the state. Also, other eligible people include the blind or disabled, currently living in a nursing unit, and people receiving LTSS. People who are eligible for both Medicare and Medicaid are included in the list.

The new Pathways for Aging program is expected to serve around 100,000 people. The latest development is expected to boost UnitedHealth’s footprint and strengthen its partnership with the state. The company serves around one million individuals in the state. It has a network of 148 facilities and approximately 38,000 caregivers in the region.

Moreover, the members receiving coverage from the current Hoosier Care Connect program are expected to continue receiving services. The latest partnership highlights the company’s growing government business.

Through its Medicare Advantage plans, UNH targets to reach out to 95% of Medicare consumers across the United States in 2023. This year is expected to be the eighth straight one witnessing above-market growth as it estimates to cater to an additional 900,000 people across its individual, group and dual special needs offerings.

Price Performance

UnitedHealth’s stock has declined 3.7% in the past year compared with the industry’s 3.1% fall.

Zacks Investment Research
Image Source: Zacks Investment Research

Zacks Rank & Key Picks

UnitedHealth currently has a Zacks Rank #3 (Hold). Meanwhile, investors interested in the broader medical space may look at players like Avanos Medical, Inc. (AVNS - Free Report) , Viemed Healthcare, Inc. (VMD - Free Report) and BioLife Solutions, Inc. (BLFS - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Avanos Medical’s 2023 earnings predicts 1.8% year-over-year growth. AVNS beat earnings estimates in all the past four quarters, with the average being 11%.

The consensus mark for Viemed’s 2023 earnings indicates an 87.5% year-over-year increase. Furthermore, the consensus estimate for VMD’s revenues in 2023 suggests 15% year-over-year growth.

The Zacks Consensus Estimate for BioLife Solutions’ 2023 earnings suggests 84.2% year-over-year growth. Also, the consensus mark for BLFS’ 2023 revenues suggests 20.7% year-over-year growth.

Published in